Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

Show other versions (1)

Abstract The U.S. Food and Drug Administration (FDA) emphasizes drug product development by Quality by Design (QbD). Critical material attributes (CMAs) are a QbD element that has an impact on pharmaceutical operations and product quality. Pharmaceutical drugs often crystallize as nee...

Full description

Bibliographic Details
Main Authors: Azad, Mohammad A, Capellades, Gerard, Wang, Allison B, Klee, David M, Hammersmith, Gregory, Rapp, Kersten, Brancazio, David, Myerson, Allan S
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering
Format: Article
Language:English
Published: Springer International Publishing 2021
Online Access:https://hdl.handle.net/1721.1/132086

Similar Items

Similar Items